Leading science, pioneering therapies
CRM Publications

Argonaute2 mediates compensatory expansion of the pancreatic β cell.

TitleArgonaute2 mediates compensatory expansion of the pancreatic β cell.
Publication TypeJournal Article
Year of Publication2014
AuthorsTattikota SG, Rathjen T, McAnulty SJ, Wessels H-H, Akerman I, van de Bunt M, Hausser J, Esguerra JLS, Musahl A, Pandey AK, You X, Chen W, Herrera PL, Johnson PR, O'Carroll D, Eliasson L, Zavolan M, Gloyn AL, Ferrer J, Shalom-Feuerstein R, Aberdam D, Poy MN
JournalCell Metab
Volume19
Issue1
Pagination122-34
Date Published2014 Jan 7
ISSN1932-7420
KeywordsAnimals, Argonaute Proteins, Cell Proliferation, Gene Expression Regulation, Gene Silencing, Humans, Insulin Resistance, Insulin-Secreting Cells, Ketogenic Diet, Mice, Mice, Obese, MicroRNAs
Abstract

Pancreatic β cells adapt to compensate for increased metabolic demand during insulin resistance. Although the microRNA pathway has an essential role in β cell proliferation, the extent of its contribution is unclear. Here, we report that miR-184 is silenced in the pancreatic islets of insulin-resistant mouse models and type 2 diabetic human subjects. Reduction of miR-184 promotes the expression of its target Argonaute2 (Ago2), a component of the microRNA-induced silencing complex. Moreover, restoration of miR-184 in leptin-deficient ob/ob mice decreased Ago2 and prevented compensatory β cell expansion. Loss of Ago2 during insulin resistance blocked β cell growth and relieved the regulation of miR-375-targeted genes, including the growth suppressor Cadm1. Lastly, administration of a ketogenic diet to ob/ob mice rescued insulin sensitivity and miR-184 expression and restored Ago2 and β cell mass. This study identifies the targeting of Ago2 by miR-184 as an essential component of the compensatory response to regulate proliferation according to insulin sensitivity.

DOI10.1016/j.cmet.2013.11.015
Alternate JournalCell Metab.
PubMed ID24361012
PubMed Central IDPMC3945818
Grant List095101 / / Wellcome Trust / United Kingdom
095101/Z/10/Z / / Wellcome Trust / United Kingdom
101033/Z/13/Z / / Wellcome Trust / United Kingdom
U01 DK089572 / DK / NIDDK NIH HHS / United States
Publication institute
Other